Merck & Co. Stock - Analyst consensus and valuation snapshot
18.06.2026 - 20:16:58 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/18/2026, 18:13 UTC. Details in the imprint.
Merck & Co. (US58933Y1055) sits firmly in the large-cap pharma camp on the New York Stock Exchange as investors track its earnings power and drug pipeline. With no fresh company announcement today, the focus turns to how analysts currently value the stock and where consensus stands.
All news and analysis on Merck & Co. stock
Follow regulatory filings, quarterly figures and analyst commentary around MRK together with historical headlines and background pieces.
What current data providers show
On 06/18/2026, trading data compiled by Robinhood shows Merck & Co. shares around $113.83, after fluctuating between $111.57 and $115.69 during the session, implying a modest intraday range for the large-cap name. Robinhood quote overview for MRK
The same data set points to a market capitalization near $281.13 billion and a price-to-earnings ratio of roughly 32.5, putting the stock on a premium multiple compared with some diversified pharma peers. Robinhood valuation metrics for Merck
How analysts currently view Merck
MarketBeat aggregates Wall Street ratings and indicates that Merck & Co. carries a broadly positive analyst stance, with the majority of covering firms rating the stock at Buy or equivalent classifications. MarketBeat consensus page for MRK
That consensus is backed by a wide base of research houses following Merck's oncology, vaccines and cardiometabolic franchises, with target prices typically embedding expectations for continued earnings growth from its leading cancer portfolio and late-stage pipeline.
The product engine behind the stock
Merck & Co. generates a substantial share of its revenue from the immuno-oncology drug Keytruda, used across multiple cancer indications, alongside vaccines like Gardasil and a range of other prescription medicines and animal health products.
Where the stock trades today
The shares of Merck & Co. (US58933Y1055) trade on the New York Stock Exchange at $113.83 as of 06/18/2026, 17:00 ET.
Key facts on Merck & Co. stock
- Company: Merck & Co., Inc.
- ISIN: US58933Y1055
- WKN: 659990
- Ticker: MRK
- Venue: NYSE
- Price (as of 06/18/2026, 17:00 ET): 113.83 USD
- Market cap: 281.13 billion USD (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: Standard & Poor's 500 index, Dow Jones Industrial Average
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
